» Articles » PMID: 25962679

New Therapeutic Targets for Cancer Bone Metastasis

Overview
Specialty Pharmacology
Date 2015 May 13
PMID 25962679
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Bone metastases are dejected consequences of many types of tumors including breast, prostate, lung, kidney, and thyroid cancers. This complicated process begins with the successful tumor cell epithelial-mesenchymal transition, escape from the original site, and penetration into the circulation. The homing of tumor cells to the bone depends on both tumor-intrinsic traits and various molecules supplied by the bone metastatic niche. The colonization and growth of cancer cells in the osseous environment, which awaken their dormancy to form micro- and macro-metastasis, involve an intricate interaction between the circulating tumor cells and local bone cells including osteoclasts, osteoblasts, adipocytes, and macrophages. We discuss the most recent advances in the identification of new molecules and novel mechanisms during each step of bone metastasis that may serve as promising therapeutic targets.

Citing Articles

Immunotherapy in the Battle Against Bone Metastases: Mechanisms and Emerging Treatments.

Hamza F, Mohammad K Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770433 PMC: 11679356. DOI: 10.3390/ph17121591.


Efficacy of Surgical Intervention in Treating Pathological Fractures of the Upper Extremity: A Retrospective Case Series.

Hashimoto K, Nishimura S, Ito T, Kakinoki R, Goto K Cureus. 2024; 16(10):e71273.

PMID: 39525158 PMC: 11550891. DOI: 10.7759/cureus.71273.


The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers.

Jafari S, Motedayyen H, Javadi P, Jamali K, Hasan-Abad A, Atapour A Front Oncol. 2024; 14:1355064.

PMID: 38559560 PMC: 10978783. DOI: 10.3389/fonc.2024.1355064.


Blocking EGR1/TGF-β1 and CD44s/STAT3 Crosstalk Inhibits Peritoneal Metastasis of Gastric Cancer.

Jin Y, Wang C, Zhang B, Sun Y, Ji J, Cai Q Int J Biol Sci. 2024; 20(4):1314-1331.

PMID: 38385088 PMC: 10878142. DOI: 10.7150/ijbs.90598.


Dosimetric impact of CT metal artifact reduction for spinal implants in stereotactic body radiotherapy planning.

Li B, Huang J, Ruan J, Peng Q, Huang S, Li Y Quant Imaging Med Surg. 2023; 13(12):8290-8302.

PMID: 38106297 PMC: 10721987. DOI: 10.21037/qims-23-442.


References
1.
Croset M, Goehrig D, Frackowiak A, Bonnelye E, Ansieau S, Puisieux A . TWIST1 expression in breast cancer cells facilitates bone metastasis formation. J Bone Miner Res. 2014; 29(8):1886-99. DOI: 10.1002/jbmr.2215. View

2.
Miwa S, Yano S, Zhang Y, Matsumoto Y, Uehara F, Yamamoto M . Tumor-targeting Salmonella typhimurium A1-R prevents experimental human breast cancer bone metastasis in nude mice. Oncotarget. 2014; 5(16):7119-25. PMC: 4196188. DOI: 10.18632/oncotarget.2226. View

3.
Glavey S, Manier S, Natoni A, Sacco A, Moschetta M, Reagan M . The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma. Blood. 2014; 124(11):1765-76. PMC: 4162107. DOI: 10.1182/blood-2014-03-560862. View

4.
Taubenberger A . In vitro microenvironments to study breast cancer bone colonisation. Adv Drug Deliv Rev. 2014; 79-80:135-44. DOI: 10.1016/j.addr.2014.10.014. View

5.
Smith M, Luker K, Garbow J, Prior J, Jackson E, Piwnica-Worms D . CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res. 2004; 64(23):8604-12. DOI: 10.1158/0008-5472.CAN-04-1844. View